Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study
2007

Study of Myeloid Sarcomas

Sample size: 13 publication Evidence: moderate

Author Information

Author(s): Alexiev Borislav A, Wang Wenle, Ning Yi, Chumsri Saranya, Gojo Ivana, Rodgers William H, Stass Sanford A, Zhao Xianfeng F

Primary Institution: University of Maryland Medical Center

Hypothesis

To evaluate the lineage differentiation of neoplastic cells in myeloid sarcoma by immunohistochemistry and correlate the results with clinicopathologic findings and cytogenetic studies.

Conclusion

An immunohistochemical panel can successfully identify the vast majority of myeloid sarcoma variants in tissue sections.

Supporting Evidence

  • The most sensitive immunohistochemical markers were CD43 and lysozyme present in all cases with myeloid sarcoma.
  • All de novo myeloid sarcoma cases showed a normal karyotype and monoblastic differentiation.
  • The most common chromosomal abnormalities in myeloid sarcoma associated with a hematopoietic disorder were trisomy 8 and inv(16).

Takeaway

Myeloid sarcoma is a type of cancer that can be hard to diagnose, but using specific tests can help doctors identify it correctly.

Methodology

Histologic and immunohistochemical examinations were performed on formalin-fixed paraffin-embedded tissue samples from 13 cases of myeloid sarcoma.

Limitations

The study had a small sample size and was limited to cases with available tissue samples.

Participant Demographics

The study included six male and seven female patients with an age range of 25 to 72 years (mean, 49.3 years).

Digital Object Identifier (DOI)

10.1186/1746-1596-2-42

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication